Ser66
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser66  -  p63 iso2 (human)

Site Information
SSTFDALsPsPAIPS   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 451600

In vivo Characterization
Methods used to characterize site in vivo:
immunoassay ( 1 ) , immunoprecipitation ( 1 ) , mass spectrometry ( 1 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 , 2 ) , western blotting ( 1 , 2 )
Relevant cell line - cell type - tissue:
epithelial ( 2 ) , HEK293T (epithelial) ( 1 ) , keratinocyte-skin ( 1 ) , squamous ( 1 )

Upstream Regulation
Putative in vivo kinases:
P38A (human) ( 1 ) , TGFBR1 (human) ( 2 )
Kinases, in vitro:
P38A (human) ( 1 ) , TGFBR1 (human) ( 2 )
Treatments:
MG132 ( 2 ) , TGF-beta ( 2 ) , UV ( 2 )

Downstream Regulation
Effects of modification on p63 iso2:
protein degradation ( 1 , 2 )
Effects of modification on biological processes:
cell growth, inhibited ( 2 )

References 

1

Choo MK, Kraft S, Missero C, Park JM (2018) The protein kinase p38α destabilizes p63 to limit epidermal stem cell frequency and tumorigenic potential. Sci Signal 11
30301786   Curated Info

2

Cherukuri P, et al. (2012) Phosphorylation of ΔNp63α via a novel TGFβ/ALK5 signaling mechanism mediates the anti-clonogenic effects of TGFβ. PLoS One 7, e50066
23166821   Curated Info